Sorrento Therapeutics stock currently trades at a fraction of a cent as of September 18, 2026, underscoring its micro-cap status in the biotechnology sector. Recent data highlight the company’s very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results